Press Releases from DelveInsight Business Research (5777 total)
Exocrine Pancreatic Insufficiency Clinical Trials 2024: EMA, PDMA, FDA Approvals …
(Albany, United States) As per DelveInsight's assessment, globally, Exocrine Pancreatic Insufficiency pipeline constitutes 5+ key companies continuously working towards developing 5+ Exocrine Pancreatic Insufficiency treatment…
Bullous Pemphigoid Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, Bullous pemphigoid pipeline constitutes 4+ key companies continuously working towards developing 4+ Bullous pemphigoid treatment therapies, analysis…
Post Bariatric Hypoglycemia Market Forecasted to Surge in Coming Years, 2024-203 …
DelveInsight's "Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Post Bariatric Hypoglycemia, historical and forecasted epidemiology as…
Oligometastatic Disease Market Report 2034: Epidemiology Data, Pipeline Therapie …
DelveInsight's "Oligometastatic Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Oligometastatic Disease, historical and forecasted epidemiology as well as…
Parkinson's Disease Psychosis Pipeline Update 2024: FDA Approvals, Therapeutic A …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Parkinson's Disease Psychosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's…
Ovarian Cancer Pipeline Assessment 2024: Therapies, Clinical Trials, Latest FDA, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ovarian Cancer pipeline constitutes 180+ key companies continuously working towards developing 200+ Ovarian Cancer…
PH-ILD Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PH-ILD pipeline constitutes key companies continuously working towards developing PH-ILD treatment therapies, analysis of…
Hepatitis C Virus Infection Pipeline Forecast 2024: FDA Approvals: Analysis of C …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hepatitis C Virus Infection pipeline constitutes 20+ key companies continuously working towards developing 20+…
Herpes Simplex Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, T …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Herpes Simplex pipeline constitutes 15+ key companies continuously working towards developing 20+ Herpes Simplex…
High-Grade Glioma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, High-Grade Glioma pipeline constitutes 150+ key companies continuously working towards developing 150+ High-Grade Glioma…
Prurigo Nodularis Pipeline Insights 2024: Therapies, Clinical Trials, and Therap …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prurigo Nodularis pipeline constitutes 5+ key companies continuously working towards developing 5+ Prurigo Nodularis…
Sarcopenia Pipeline Analysis 2024: FDA Approvals, Medication, Clinical Trials, T …
(Albany, United States) As per DelveInsight's assessment, globally, Sarcopenia pipeline constitutes 10+ key companies continuously working towards developing 10+ Sarcopenia treatment therapies, analysis of Clinical…
Thrombocytopenia Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Tria …
(Albany, United States) As per DelveInsight's assessment, globally, Thrombocytopenia pipeline constitutes 25+ key companies continuously working towards developing 25+ Thrombocytopenia treatment therapies, analysis of Clinical…
Hepatic Encephalopathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Hepatic Encephalopathy pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatic Encephalopathy treatment therapies, analysis…
Hemophilia B Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
(Albany, USA) As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Hemophilia B therapeutics…
Homocystinuria Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies …
(Albany, United States) As per DelveInsight's assessment, globally, Homocystinuria pipeline constitutes 3+ key companies continuously working towards developing 3+ Homocystinuria treatment therapies, analysis of Clinical…
Clostridium Difficile Infections Clinical Trials 2024: EMA, PDMA, FDA Approvals, …
(Albany, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium Difficile Infections treatment…
Complicated Urinary Tract Infection (UTI) Clinical Trials 2024: EMA, PDMA, FDA A …
(Albany, United States) As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Complicated Urinary…
IgG4-Related Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, IgG4-Related Disease pipeline constitutes 10+ key companies continuously working towards developing 10+ IgG4-Related Disease treatment therapies, analysis…
Acute Pain Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatment …
(Albany, United States) As per DelveInsight's assessment, globally, Acute Pain pipeline constitutes 25+ key companies continuously working towards developing 25+ Acute Pain treatment therapies, analysis…
Acute On Chronic Liver Failure Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …
(Albany, United States) As per DelveInsight's assessment, globally, Acute On Chronic Liver Failure pipeline constitutes 4+ key companies continuously working towards developing 6+ Acute On…
PD-1 Non-Small Cell Lung Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, …
The prevalence of non-small cell lung cancer has been rising over the past few years, which prompts a growing demand for treatment options. The introduction…
Fabry Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatm …
(Albany, United States) As per DelveInsight's assessment, globally, Fabry Disease pipeline constitutes 18+ key companies continuously working towards developing 18+ Fabry Disease treatment therapies, analysis…
Systemic Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, USA) DelveInsight's, "Systemic Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Systemic Sclerosis pipeline landscape.…
Ankylosing Spondylitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Ankylosing Spondylitis pipeline constitutes 20+ key companies continuously working towards developing 20+ Ankylosing Spondylitis treatment therapies, analysis…
NSCLC Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, Drug …
(Albany, USA) DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ NSCLC Companies and 150+ pipeline drugs in the Non-Small-Cell Lung…
Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trials 2024: EMA, PDMA, FDA …
(Albany, USA) DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Non Muscle…
Crohn's Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 70+ key companies continuously working towards developing 80+ Crohn's Disease treatment therapies, analysis…
Hemophilia A Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
Hemophilia A companies are Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd,…
Ascites Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, M …
(Albany, United States) As per DelveInsight's assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies, analysis of Clinical…
Genital Warts Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therap …
(Albany, United States) As per DelveInsight's assessment, globally, Genital Warts pipeline constitutes 30+ key companies continuously working towards developing 30+ Genital Warts treatment therapies, analysis…
Giant-Cell Arteritis Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, United States) As per DelveInsight's assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards developing 6+ Giant-Cell Arteritis treatment therapies, analysis…
Mydriasis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mydriasis pipeline constitutes 3+ key companies continuously working towards developing 3+ Mydriasis treatment therapies, analysis…
Nasal Polyposis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Nasal Polyposis pipeline constitutes 4+ key companies continuously working towards developing 4+ Nasal Polyposis treatment therapies, analysis…
Aplastic Anemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Pipeline, Medica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Aplastic Anemia pipeline constitutes 5+ key companies continuously working towards developing 8+ Aplastic Anemia treatment…
Eosinophilic Esophagitis Clinical Trials 2024: FDA Approvals, Medication, Therap …
(Albany, USA) DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Eosinophilic Esophagitis pipeline landscape.…
Essential Thrombocythemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medica …
(Albany, United States) As per DelveInsight's assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential Thrombocythemia treatment therapies, analysis…
IgA nephropathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
IgA nephropathy companies are Chinook Therapeutics, Inc., RemeGen Co., Ltd., Novartis, Jiangsu HengRui Medicine Co., Ltd., Ionis Pharmaceuticals, Inc., Vera Therapeutics, Inc., Eledon Pharmaceuticals, Guangdong…
C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Clinical Trials 2024: FDA Appro …
(Albany, USA) DelveInsight's, "C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in…
Candidemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, …
(Albany, United States) As per DelveInsight's assessment, globally, Candidemia pipeline constitutes 4+ key companies continuously working towards developing 4+ Candidemia treatment therapies, analysis of Clinical…
CAR T-Cell Therapy for Non-Hodgkin's lymphoma Pipeline Analysis 2024: EMA, PDMA, …
(Albany, United States) As per DelveInsight's assessment, globally, CAR T-Cell Therapy for Non-Hodgkin's lymphoma pipeline constitutes 5+ key companies continuously working towards developing 5+ CAR…
Cystinosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies …
(Albany, USA) DelveInsight's 'Cystinosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development,…
Dermatomyositis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
Dermatomyositis companies are Kezar Life Sciences, Argenx, Pfizer, CSL Behring, Viela Bio, PAEAN Biotechnology, Alexion Pharmaceuticals, others.
(Albany, United States) As per DelveInsight's assessment, globally, Dermatomyositis…
Diabetic Kidney Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicati …
(Albany, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease treatment therapies, analysis…
Diabetic Macular Edema Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, USA) DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2024" report provides comprehensive insights about 60+ Diabetic Macular Edema companies and 65+ Diabetic Macular Edema pipeline…
Glioblastoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
(Albany, USA) As per DelveInsight's assessment, globally, Glioblastoma pipeline constitutes 190+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analysis of Clinical Trials,…
Hematopoietic Stem Cell Transplantation Clinical Trials 2024: EMA, PDMA, FDA App …
(Albany, United States) As per DelveInsight's assessment, globally, Hematopoietic Stem Cell Transplantation pipeline constitutes 20+ key companies continuously working towards developing 20+ Hematopoietic Stem Cell…
Lupus Nephritis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Trea …
(Albany, USA) As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 35+ pipeline drugs in the Lupus Nephritis therapeutics…
Metastatic Colorectal Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Med …
(Albany, United States) As per DelveInsight's assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 80+ key companies continuously working towards developing 100+ Metastatic Colorectal Cancer treatment…
Multiple Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, USA) DelveInsight's, "Multiple Sclerosis Pipeline Insight" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It…
